Abstract
A young woman experienced complete heart block, leading to Torsades de pointes. Cardiac
18F-fluorodeoxyglucose/positron emission tomography was used to confirm the resolution
of her acute myocarditis and was critical to the decision-making process that prevented
unnecessary pacemaker insertion.
Résumé
Une jeune femme a subi un bloc cardiaque complet qui a entraîné des torsades de pointes.
L’imagerie cardiaque par tomographie par émission de positons au [18F]-fluorodésoxyglucose
qui a été utilisée pour confirmer la résolution de sa myocardite aiguë était essentielle
au processus de décision en vue d’éviter l’insertion inutile d’un stimulateur cardiaque.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.J Nucl Cardiol. 2013; 20: 297-306
- Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.J Cardiovasc Electrophysiol. 2014; 25: 875-881
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.Eur Heart J. 2013; 34: 2636-2648
- Comparison of 18F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.Eur J Nucl Med Mol Imaging. 2016; 43: 259-269
Article info
Publication history
Published online: August 21, 2016
Accepted:
August 16,
2016
Received:
July 7,
2016
Footnotes
See page 293.e5 for disclosure information.
Identification
Copyright
© 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
